Switch theme
Sign up to access all valuation multiples
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
2015
15K+
LTM Revenue $3.2B
LTM EBITDA $523M
$6.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Surgery Partners has a last 12-month revenue of $3.2B and a last 12-month EBITDA of $523M.
In the most recent fiscal year, Surgery Partners achieved revenue of $3.1B and an EBITDA of $501M.
Surgery Partners expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Surgery Partners valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.7B | $3.1B | XXX | XXX | XXX |
| Gross Profit | $575M | $648M | XXX | XXX | XXX |
| Gross Margin | 21% | 21% | XXX | XXX | XXX |
| EBITDA | $446M | $501M | XXX | XXX | XXX |
| EBITDA Margin | 16% | 16% | XXX | XXX | XXX |
| Net Profit | -$54.6M | -$11.9M | XXX | XXX | XXX |
| Net Margin | -2% | 0% | XXX | XXX | XXX |
| Net Debt | $2.3B | $2.6B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Surgery Partners's stock price is $21.
Surgery Partners has current market cap of $2.7B, and EV of $6.2B.
See Surgery Partners trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6.2B | $2.7B | XXX | XXX | XXX | XXX | $0.98 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Surgery Partners has market cap of $2.7B and EV of $6.2B.
Surgery Partners's trades at 1.9x LTM EV/Revenue multiple, and 11.8x LTM EBITDA.
Analysts estimate Surgery Partners's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Surgery Partners and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $6.2B | XXX | XXX | XXX |
| EV/Revenue | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 12.3x | XXX | XXX | XXX |
| P/E | -16.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 29.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSurgery Partners's NTM/LTM revenue growth is 9%
Surgery Partners's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $19K for the same period.
Over next 12 months, Surgery Partners's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Surgery Partners's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Surgery Partners and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 16% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 25% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $19K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 9% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Surgery Partners acquired XXX companies to date.
Last acquisition by Surgery Partners was XXXXXXXX, XXXXX XXXXX XXXXXX . Surgery Partners acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Surgery Partners founded? | Surgery Partners was founded in 2015. |
| Where is Surgery Partners headquartered? | Surgery Partners is headquartered in United States of America. |
| How many employees does Surgery Partners have? | As of today, Surgery Partners has 15K+ employees. |
| Who is the CEO of Surgery Partners? | Surgery Partners's CEO is Mr. J. Eric Evans. |
| Is Surgery Partners publicy listed? | Yes, Surgery Partners is a public company listed on NAS. |
| What is the stock symbol of Surgery Partners? | Surgery Partners trades under SGRY ticker. |
| When did Surgery Partners go public? | Surgery Partners went public in 2015. |
| Who are competitors of Surgery Partners? | Similar companies to Surgery Partners include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Surgery Partners? | Surgery Partners's current market cap is $2.7B |
| What is the current revenue of Surgery Partners? | Surgery Partners's last 12-month revenue is $3.2B. |
| What is the current EBITDA of Surgery Partners? | Surgery Partners's last 12-month EBITDA is $523M. |
| What is the current EV/Revenue multiple of Surgery Partners? | Current revenue multiple of Surgery Partners is 1.9x. |
| What is the current EV/EBITDA multiple of Surgery Partners? | Current EBITDA multiple of Surgery Partners is 11.8x. |
| What is the current revenue growth of Surgery Partners? | Surgery Partners revenue growth between 2023 and 2024 was 14%. |
| Is Surgery Partners profitable? | Yes, Surgery Partners is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
